Devane J - Search Results

1

A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea.

Coyle VM, Lungulescu D, Toganel C, Niculescu A, Pop S, Ciuleanu T, Cebotaru C, Devane J, Martin M, Wilson RH. Coyle VM, et al. Among authors: devane j. Br J Cancer. 2013 Mar 19;108(5):1027-33. doi: 10.1038/bjc.2013.35. Epub 2013 Mar 5. Br J Cancer. 2013. PMID: 23462724 Free PMC article. Clinical Trial.

2

Dose proportionality of pharmacokinetics with a cr-verapamil formulation.

Mulligan S, Devane J, Martin M. Mulligan S, et al. Among authors: devane j. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:304-11. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820898

3

Pharmacokinetic characteristics of a novel controlled-release sprinkle formulation of salbutamol.

Mulligan S, Devane J, Martin M. Mulligan S, et al. Among authors: devane j. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:312-4. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820899

4

Distal ileum and colon: targeted sites for 5-ASA release.

Devane J, Mulligan S, Martin M. Devane J, et al. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:300-3. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820897 Clinical Trial.

5

A short 2 week dose titration regimen reduces the severity of flu-like symptoms with initial interferon gamma-1b treatment.

Devane JG, Martin ML, Matson MA. Devane JG, et al. Curr Med Res Opin. 2014 Jun;30(6):1179-87. doi: 10.1185/03007995.2014.899209. Epub 2014 Mar 13. Curr Med Res Opin. 2014. PMID: 24576196 Clinical Trial.

6

In-vivo pharmacokinetic characteristics of a transdermal phenylpropanolamine (PPA) preparation.

Devane J, Mulligan S, Foynes M, Martin M. Devane J, et al. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:297-9. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820895

7

Clinical and pharmacokinetic properties of a transdermal nicotine patch.

Mulligan SC, Masterson JG, Devane JG, Kelly JG. Mulligan SC, et al. Among authors: devane jg. Clin Pharmacol Ther. 1990 Mar;47(3):331-7. doi: 10.1038/clpt.1990.36. Clin Pharmacol Ther. 1990. PMID: 2311334 Clinical Trial.

8

New developments in sustained-release antihypertensive therapy: formulation and pharmacokinetic considerations.

Devane JG, Mulligan S, Kavanagh M, Davis SS, Sparrow RA, Wilding IR. Devane JG, et al. Am J Cardiol. 1992 Apr 30;69(13):23E-27E. doi: 10.1016/0002-9149(92)90014-p. Am J Cardiol. 1992. PMID: 1575173

9

Pharmacokinetic properties and clinical efficacy of once-daily sustained-release naproxen.

Kelly JG, Kinney CD, Devane JG, Mulligan S, Colgan BV. Kelly JG, et al. Among authors: devane jg. Eur J Clin Pharmacol. 1989;36(4):383-8. doi: 10.1007/BF00558300. Eur J Clin Pharmacol. 1989. PMID: 2661242 Clinical Trial.

10

IPDAS: a novel technology brings new benefits when applied to naproxen sodium.

Devane JG, Butler J, Mulligan S. Devane JG, et al. Am J Orthop (Belle Mead NJ). 1996 Sep;25(9 Suppl):7-13. Am J Orthop (Belle Mead NJ). 1996. PMID: 8886212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters